Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 1,484 Cr.
- Current Price ₹ 290
- High / Low ₹ 409 / 145
- Stock P/E
- Book Value ₹ 151
- Dividend Yield 0.00 %
- ROCE 5.49 %
- ROE -4.29 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Debtor days have improved from 34.6 to 25.5 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.05% over past five years.
- Company has a low return on equity of -0.25% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
1,449 | 1,526 | 1,691 | 2,000 | 1,675 | 1,853 | |
1,347 | 1,372 | 1,560 | 1,861 | 1,544 | 1,753 | |
Operating Profit | 102 | 155 | 131 | 139 | 132 | 100 |
OPM % | 7% | 10% | 8% | 7% | 8% | 5% |
13 | 7 | 6 | 6 | 14 | 16 | |
Interest | 68 | 72 | 60 | 73 | 76 | 72 |
Depreciation | 45 | 47 | 48 | 50 | 60 | 50 |
Profit before tax | 2 | 43 | 29 | 23 | 10 | -5 |
Tax % | -53% | 43% | 44% | 49% | -2% | 402% |
3 | 25 | 16 | 12 | 11 | -27 | |
EPS in Rs | 0.60 | 5.86 | 3.89 | 2.86 | 2.52 | -5.31 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 3% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -355% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | 0% |
Last Year: | -4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 |
Reserves | 392 | 416 | 432 | 442 | 452 | 721 |
584 | 564 | 634 | 739 | 655 | 488 | |
419 | 417 | 625 | 517 | 839 | 683 | |
Total Liabilities | 1,437 | 1,440 | 1,734 | 1,740 | 1,987 | 1,944 |
733 | 706 | 666 | 866 | 849 | 877 | |
CWIP | 17 | 9 | 50 | 17 | 29 | 23 |
Investments | 14 | 14 | 14 | 16 | 16 | 16 |
673 | 711 | 1,004 | 842 | 1,093 | 1,028 | |
Total Assets | 1,437 | 1,440 | 1,734 | 1,740 | 1,987 | 1,944 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
240 | 129 | 40 | 185 | 196 | -1 | |
-28 | -8 | -47 | -217 | -45 | -61 | |
-211 | -120 | 7 | 31 | -151 | 63 | |
Net Cash Flow | 0 | 0 | 1 | -1 | 1 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 30 | 39 | 38 | 39 | 40 | 26 |
Inventory Days | 131 | 147 | 250 | 194 | ||
Days Payable | 124 | 133 | 197 | 141 | ||
Cash Conversion Cycle | 37 | 53 | 38 | 39 | 92 | 79 |
Working Capital Days | 42 | 56 | 70 | 54 | 48 | 67 |
ROCE % | 11% | 8% | 8% | 7% | 5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
31 May - Q4 FY25 earnings: 11% revenue growth, 3x EBITDA target by FY29, 200kL/day grain ethanol plant by Q4 FY26.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30 May - Scheduled analyst meeting on June 6, 2025; investor presentation uploaded online.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
27 May - Monitoring Agency Report: Rs.1.40 Cr excess IPO funds used for general corporate purposes, within SEBI norms.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
26 May - Revised Q4 FY25 financial results correcting tax expense classification; no impact on profitability.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
26 May - Revised Investor Presentation for the Q4 and FY 25
Annual reports
Concalls
-
May 2025Transcript PPT REC
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.